Inoviq
Inoviq is an Australian biotechnology company focused on developing and commercializing innovative cancer diagnostic products. The company's focus is on improving cancer detection and monitoring through its proprietary technologies. Inoviq aims to address unmet needs in cancer diagnostics, offering potential benefits for patients and healthcare providers.
Short position
Inoviq (ASX:IIQ) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 27 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.58% in October 2025. IIQ is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Inoviq (IIQ) short interest history
IIQ Short Interest History
- 30-day change
- 0.00pp
- 90-day change
- 0.00pp
- 1-year change
- -0.00pp
- All-time high
- 0.58% (October 2025)
- All-time low
- 0.00% (October 2026)
Is IIQ heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #767 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has IIQ's short interest changed recently?
Over the past 30 days Inoviq's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest IIQ's short interest has been?
Since 2022, Inoviq's short interest peaked at 0.58% in October 2025 and bottomed at 0.00% in October 2026.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2022. See our methodology.